CAMP4 Therapeutics Corporation(CAMP)
$3.80-0.29 (-7.09%)
CAMP
CAMP4 Therapeutics Corporation financials statements
$3.80
At close:-0.29 (-7.09%)
Want to see CAMP full AI Analyst Report?
CAMP4 Therapeutics Corporation (CAMP) Ratios
146 Followers
CAMP4 Therapeutics Corporation Ratios
CAMP's free cash flow for Q3 2026 was $-8.90M. For the 2026 fiscal year, CAMP's free cash flow was decreased by $-740.00K and operating cash flow was $-8.16M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Nov 23 | Feb 23 | Feb 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 7.35 | 6.92 | 5.13 | 10.62 | 2.04 |
| Quick Ratio | 7.35 | 6.92 | 5.13 | 10.62 | 1.83 |
| Cash Ratio | 7.06 | 6.67 | 4.92 | 10.47 | 0.96 |
| Solvency Ratio | -1.12 | -3.30 | -0.27 | -0.24 | -0.03 |
| Operating Cash Flow Ratio | -1.90 | -4.75 | -5.66 | -4.85 | -0.04 |
| Short-Term Operating Cash Flow Coverage | -103.33 | 0.00 | 0.00 | 0.00 | -0.55 |
| Net Current Asset Value | $ 43.99M | $ 51.22M | $ -138.66M | $ -95.67M | $ -128.52M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.02 | 0.11 | 0.21 | 0.12 | 0.52 |
| Debt-to-Equity Ratio | 0.04 | 0.14 | -0.09 | -0.16 | 2.61 |
| Debt-to-Capital Ratio | 0.04 | 0.12 | -0.10 | -0.19 | 0.72 |
| Long-Term Debt-to-Capital Ratio | 0.03 | 0.00 | 0.00 | 0.00 | 0.72 |
| Financial Leverage Ratio | 2.47 | 1.24 | -0.44 | -1.32 | 5.02 |
| Debt Service Coverage Ratio | -176.30 | 0.00 | 0.00 | -7.05 | 0.28 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | -7.19 | -1.00 |
| Debt to Market Cap | 0.01 | 0.00 | 0.00 | 0.00 | 0.55 |
| Interest Debt Per Share | 0.06 | 0.44 | 0.96 | 0.52 | 6.37 |
| Net Debt to EBITDA | 2.13 | 1.08 | 0.53 | 1.60 | 15.76 |
| Profitability Margins | |||||
| Gross Profit Margin | 53.14% | 100.00% | 100.00% | 0.00% | 41.20% |
| EBIT Margin | -1488.31% | -8142.33% | -14822.57% | 0.00% | -5.18% |
| EBITDA Margin | -1441.45% | -7882.21% | -14343.14% | 0.00% | 2.53% |
| Operating Profit Margin | -1488.31% | -8142.33% | -14822.57% | 0.00% | -5.18% |
| Pretax Profit Margin | -2298.54% | -7943.40% | -14083.14% | 0.00% | -10.16% |
| Net Profit Margin | -2298.54% | -7943.40% | -14083.14% | 0.00% | -10.53% |
| Continuous Operations Profit Margin | -2298.54% | -7943.40% | -14083.14% | 0.00% | -10.53% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 103.62% |
| EBT Per EBIT | 154.44% | 97.56% | 95.01% | 98.20% | 196.31% |
| Return on Assets (ROA) | -68.25% | -66.14% | -89.71% | -43.09% | -7.74% |
| Return on Equity (ROE) | -168.55% | -82.02% | 39.84% | 57.00% | -38.85% |
| Return on Capital Employed (ROCE) | -50.89% | -77.26% | -110.06% | -47.57% | -4.98% |
| Return on Invested Capital (ROIC) | -50.75% | -73.94% | -103.35% | -46.41% | -4.86% |
| Return on Tangible Assets | -68.25% | -66.14% | -89.71% | -43.09% | -11.32% |
| Earnings Yield | -43.17% | -50.87% | -37.92% | -11.42% | -8.24% |
| Efficiency Ratios | |||||
| Receivables Turnover | 22.57 | 6.04 | 0.79 | 0.00 | 5.05 |
| Payables Turnover | 9.01 | 0.00 | 0.00 | 0.00 | 5.65 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 8.62 |
| Fixed Asset Turnover | 1.28 | 0.06 | 0.03 | 0.00 | 5.91 |
| Asset Turnover | 0.03 | 0.01 | 0.01 | 0.00 | 0.74 |
| Working Capital Turnover Ratio | 0.05 | 0.01 | 0.01 | 0.00 | 2.86 |
| Cash Conversion Cycle | -24.36 | 60.46 | 460.94 | 0.00 | 50.04 |
| Days of Sales Outstanding | 16.17 | 60.46 | 460.94 | 0.00 | 72.29 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 42.34 |
| Days of Payables Outstanding | 40.53 | 0.00 | 0.00 | 0.00 | 64.58 |
| Operating Cycle | 16.17 | 60.46 | 460.94 | 0.00 | 114.63 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.97 | -2.34 | -3.64 | -1.07 | -0.12 |
| Free Cash Flow Per Share | -0.98 | -2.36 | -3.70 | -1.18 | -0.50 |
| Dividend Paid and CapEx Coverage Ratio | -105.92 | -103.32 | -65.13 | -9.58 | -0.32 |
| Capital Expenditure Coverage Ratio | -105.92 | -103.32 | -65.13 | -9.58 | -0.32 |
| Operating Cash Flow Coverage Ratio | -14.97 | -5.27 | -3.78 | -3.11 | -0.02 |
| Operating Cash Flow to Sales Ratio | -8.45 | -69.88 | -126.16 | 0.00 | -0.01 |
| Free Cash Flow Yield | -16.02% | -45.18% | -34.49% | -11.00% | -4.63% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -2.31 | -1.97 | -2.64 | -8.76 | -12.13 |
| Price-to-Sales (P/S) Ratio | 53.24 | 156.16 | 371.36 | 0.00 | 1.28 |
| Price-to-Book (P/B) Ratio | 3.90 | 1.61 | -1.05 | -4.99 | 4.71 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -6.24 | -2.21 | -2.90 | -9.09 | -21.58 |
| Price-to-Operating Cash Flow Ratio | -6.30 | -2.23 | -2.94 | -10.04 | -89.60 |
| Price-to-Earnings Growth (PEG) Ratio | 6.15 | 0.06 | -0.01 | -3.85 | -0.29 |
| Enterprise Value Multiple | -1.56 | -0.90 | -2.06 | -7.17 | 66.21 |
| Enterprise Value | 78.69M | 46.43M | 103.29M | 316.20M | 495.98M |
| EV to EBITDA | -1.56 | -0.90 | -2.06 | -7.17 | 66.21 |
| EV to Sales | 22.50 | 71.21 | 295.12 | 0.00 | 1.68 |
| EV to Free Cash Flow | -2.64 | -1.01 | -2.30 | -7.43 | -28.32 |
| EV to Operating Cash Flow | -2.66 | -1.02 | -2.34 | -8.20 | -117.59 |
| Tangible Book Value Per Share | 1.57 | 3.24 | -10.20 | -2.15 | -1.33 |
| Shareholders’ Equity Per Share | 1.57 | 3.24 | -10.20 | -2.15 | 2.27 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | -0.04 |
| Revenue Per Share | 0.12 | 0.03 | 0.03 | 0.00 | 8.39 |
| Net Income Per Share | -2.65 | -2.66 | -4.07 | -1.22 | -0.88 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.04 |
| Interest Burden | 1.54 | 0.98 | 0.95 | 0.98 | 1.96 |
| Research & Development to Revenue | 10.92 | 59.54 | 116.05 | 0.00 | 0.10 |
| SG&A to Revenue | 4.96 | 22.89 | 33.18 | 0.00 | 0.18 |
| Stock-Based Compensation to Revenue | 1.14 | 6.18 | 8.31 | 0.00 | 0.04 |
| Income Quality | 0.37 | 0.88 | 0.90 | 0.87 | 0.15 |
Currency in USD
